Comerica Bank
KYMR icon

Comerica Bank’s Kymera Therapeutics KYMR Stock Holding History

Comerica Bank’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.88M Sell
49,812
-1,611
-3% -$109K 0.02% 750
2025
Q3 		$2.91M Buy
51,423
+2,310
+5% +$104K 0.01% 957
2025
Q2 		$2.14M Buy
49,113
+27,739
+130% +$955K 0.01% 1095
2025
Q1 		$585K Buy
21,374
+743
+4% +$27.1K ﹤0.01% 1772
2024
Q4 		$830K Sell
20,631
-17,442
-46% -$788K ﹤0.01% 1657
2024
Q3 		$1.8M Buy
38,073
+35,133
+1,195% +$1.55M 0.01% 1199
2024
Q2 		$87.8K Sell
2,940
-384
-12% -$13.3K ﹤0.01% 2591
2024
Q1 		$134K Buy
3,324
+400
+14% +$14.3K ﹤0.01% 2447
2023
Q4 		$74.4K Buy
2,924
+1,415
+94% +$25.3K ﹤0.01% 2597
2023
Q3 		$21K Buy
+1,509
New +$30.3K ﹤0.01% 2988

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Comerica Bank's KYMR Position: Q4 2025 in Review

Comerica Bank reduced its Kymera Therapeutics (KYMR) stake by 3.1% in Q4 2025, selling an estimated $109K and leaving 49,812 shares worth $3.88M. The position accounts for 0.02% of the portfolio, ranked #750.

Comerica Bank first reported a position in KYMR in Q3 2023 and has held it in 10 quarters since. 254 funds tracked by Wall St. Rank hold KYMR as of Q4 2025.

  • Comerica Bank held 49,812 shares of Kymera Therapeutics worth $3.88M as of Q4 2025.
  • Comerica Bank sold 1,611 Kymera Therapeutics shares in Q4 2025, an estimated $109K.
  • Kymera Therapeutics made up 0.02% of Comerica Bank's portfolio in Q4 2025, its #750 holding.
  • Comerica Bank first reported a position in Kymera Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 254 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.